Loading...
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies
Duan, Hongying Chen, Xuejun Boyington, Jeffrey C. Cheng, Cheng Zhang, Yi Jafari, Alexander J. Stephens, Tyler Tsybovsky, Yaroslav Kalyuzhniy, Oleksandr Zhao, Peng
Duan, Hongying
Chen, Xuejun
Boyington, Jeffrey C.
Cheng, Cheng
Zhang, Yi
Jafari, Alexander J.
Stephens, Tyler
Tsybovsky, Yaroslav
Kalyuzhniy, Oleksandr
Zhao, Peng
Citations
Altmetric:
Abstract
An important class of HIV-1 broadly neutralizing antibodies, termed the VRC01 class, targets the conserved CD4-binding site (CD4bs) of the envelope glycoprotein (Env). An engineered Env outer domain (OD) eOD-GT8 60-mer nanoparticle has been developed as a priming immunogen for eliciting VRC01-class precursors and is planned for clinical trials. However, a substantial portion of eOD-GT8-elicited antibodies target non-CD4bs epitopes, potentially limiting its efficacy. We introduced N-linked glycans into non-CD4bs surfaces of eOD-GT8 to mask irrelevant epitopes and evaluated these mutants in a mouse model that expressed diverse immunoglobulin heavy chains containing human IGHV1-2∗02, the germline VRC01 VH segment. Compared to the parental eOD-GT8, a mutant with five added glycans stimulated significantly higher proportions of CD4bs-specific serum responses and CD4bs-specific immunoglobulin G+ B cells including VRC01-class precursors. These results demonstrate that glycan masking can limit elicitation of off-target antibodies and focus immune responses to the CD4bs, a major target of HIV-1 vaccine design.
Description
This work is licensed under a Creative Commons Attribution Non-Commercial-No Derivatives 4.0 International License.
Date
2018-08-21
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Files
Loading...
Duan_2018.pdf
Adobe PDF, 2.01 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Duan, H., Chen, X., Boyington, J. C., Cheng, C., Zhang, Y., Jafari, A. J., … Mascola, J. R. (2018). Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies. Immunity, 49(2), 301–311.e5. doi:10.1016/j.immuni.2018.07.005